2 ms·
> I hope we're not on the path to reducing rigorous testing and vetting of medicines in exchange for cheaper prices The FDA has extremely long review cycles. T
by ekianjo 8y ago
> I hope we're not on the path to reducing rigorous testing and vetting of medicines in exchange for cheaper prices
The FDA has extremely long review cycles. To say that this could be not be improved, while still keeping the same standards (or even better ones) is unlikely. Anyway, I don't think it's likely that we will see anyone touching the patent system anytime soon, so it's merely a thought exercise at this stage.